The grant will fund development of the iGLOBE LifeStrip, a continuous subcutaneous monitor that will measure Insulin, Glucose, Lactate, Oxygen, and Beta Hydroxybutyrate (a ketone body). The iGLOBE is an exciting new frontier in the management and treatment of type 1 diabetes. Read about the funding here.

Elliot Botvinick awarded $3.5 million grant from The Leona M. and Harry B. Helmsley Charitable Trust